Survival Outcome with Bevacizumab: Activation of the Phosphatidylinositol-3 Kinase (PI3K) Pathway Due to PIK3CA Mutations or PTEN Loss Makes a Difference.

被引：1
|
作者：
Vidal, M. [1 ]
Di Cosimo, S. [1 ]
Torrejon, D. [1 ]
Saura, C. [1 ]
Gomez-Pardo, P. [1 ]
Perez-Garcia, J. [1 ]
Munoz-Couselo, E. [1 ]
Bellet, M. [1 ]
Sanchez-Olle, G. [1 ]
De Mattos-Arruda, L. [1 ]
Oliveira, M. [1 ]
Tabernero, J. [1 ]
Baselga, J. [1 ]
Cortes, J. [1 ]
机构：
[1] Univ Autonoma Barcelona, Vall dHebron Inst Oncol, Vall dHebron Univ Hosp, E-08193 Barcelona, Spain
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P5-13-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-13-01
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Activation of the PI3K/AKT pathway and PIK3CA mutations in Merkel cell carcinoma
    Hafner, C.
    Houben, R.
    Baeurle, A.
    Landthaler, M.
    Becker, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2010, 8 (09): : 739 - 739
  • [2] The effect of LKB1 on the PI3K/Akt pathway activation in association with PTEN and PIK3CA in HNC
    Ekizoglu, S.
    Dogan, S.
    Ulker, D.
    Seven, D.
    Gozen, E. D.
    Karaman, E.
    Buyru, N.
    CLINICAL OTOLARYNGOLOGY, 2015, 40 (06) : 622 - 628
  • [3] Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer
    Ito, Chie
    Nishizuka, Satoshi S.
    Ishida, Kazuyuki
    Uesugi, Noriyuki
    Sugai, Tamotsu
    Tamura, Gen
    Koeda, Keisuke
    Sasaki, Akira
    JOURNAL OF SURGICAL RESEARCH, 2017, 212 : 195 - 204
  • [4] Double PIK3CA mutations in cis enhance PI3Kα oncogene activation and sensitivity to PI3Kα inhibitors in breast cancer
    Vasan, N.
    Razavi, P.
    Johnson, J. L.
    Shao, H.
    Reznik, E.
    Smith, M. L.
    Sebra, R.
    Cantley, L. C.
    Scaltriti, M.
    Baselga, J.
    ANNALS OF ONCOLOGY, 2019, 30 : 1 - 1
  • [5] PIK3CA cooperates with other phosphatidylinositol 3′-kinase pathway mutations to effect oncogenic transformation
    Oda, Katsutoshi
    Okada, Jennifer
    Timmerman, Luika
    Rodriguez-Viciana, Pablo
    Stokoe, David
    Shoji, Keiko
    Taketani, Yuji
    Kuramoto, Hiroyuki
    Knight, Zachary A.
    Shokat, Kevan M.
    McCormick, Frank
    CANCER RESEARCH, 2008, 68 (19) : 8127 - 8136
  • [6] Hyperglycemia secondary to phosphatidylinositol-3 kinase (PI3K) inhibition
    Sriravindrarajah, Arunan
    Hurwitz, Joshua
    Lim, Elgene
    Greenfield, Jerry R.
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2024, 2024 (04):
  • [7] PIK3CA and PIK3R1 mutations in cancer: from the mechanism of activation to PI3K targeted therapies
    Rzepecka, Iwona K.
    Tysarowski, Andrzej
    ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [8] Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer
    Malentacchi, Francesca
    Turrini, Irene
    Sorbi, Flavia
    Projetto, Elisabetta
    Castiglione, Francesca
    Fambrini, Massimiliano
    Petraglia, Felice
    Pillozzi, Serena
    Noci, Ivo
    ONCOLOGY REPORTS, 2019, 41 (03) : 1560 - 1574
  • [9] PIK3CA mutations and response to PI3K and MEK targeted therapies in NSCLC
    Heavey, S.
    Davies, M. A.
    O'Byrne, K. J.
    Gately, K.
    LUNG CANCER, 2013, 79 : S3 - S3
  • [10] PIK3CA Mutations PREDICT RESPONSE TO PI3K/AKT/mTOR INHIBITORS
    不详
    CANCER DISCOVERY, 2012, 2 (03) : 205 - 205
12345